• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KLF7通过调控SLC1A5介导的色氨酸代谢促进肝细胞癌进展。

KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5-Mediated Tryptophan Metabolism.

作者信息

Chai Bao, Zhang Anhong, Liu Yang, Zhang Xi, Kong Pengzhou, Zhang Zhuowei, Guo Yarong

机构信息

Department of Gastroenterology, Shanxi Bethune Hospital, Shanxi Academy of Medical sciences, TongilShanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Department of Surgery, The First Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

出版信息

J Cell Mol Med. 2024 Dec;28(23):e70245. doi: 10.1111/jcmm.70245.

DOI:10.1111/jcmm.70245
PMID:39648156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11625504/
Abstract

Krüppel-like factor 7 is a transcriptional activator and acts as an oncogene in human cancers, including hepatocellular carcinoma (HCC). Tryptophan metabolism is important for HCC cell proliferation, metastasis, and invasion. It is unclear whether KLF7 could regulate Trp metabolism in HCC. In this study, we found that Trp metabolism was suppressed in HCC cells with KLF7 knockdown. The mRNA and protein levels of SLC1A5, SLC7A5, and TPH1, as well as the content of Trp and serotonin, were reduced after KLF7 knockdown, and were potentiated following KLF7 overexpression. Increasing the content of serotonin could restore the malignancy of tumour cells in vitro and tumour growth in vivo. Conversely, decreasing the content of serotonin suppressed HCC cell proliferation. The binding activity of KLF7 was on the promoter of SLC1A5, and KLF7 positively regulated the expression of SLC1A5. KLF7 contributed to the proliferation and migration of HCC cells by up-regulation of SLC1A5. Collectively, KLF7 promotes the progression of HCC through regulating Trp metabolism. The newly identified axis of KLF7/ SLC1A5 in HCC could represent a potential target for HCC therapy.

摘要

Krüppel样因子7是一种转录激活因子,在包括肝细胞癌(HCC)在内的人类癌症中作为癌基因发挥作用。色氨酸代谢对肝癌细胞的增殖、转移和侵袭很重要。目前尚不清楚KLF7是否能调节肝癌中的色氨酸代谢。在本研究中,我们发现KLF7敲低的肝癌细胞中色氨酸代谢受到抑制。KLF7敲低后,SLC1A5、SLC7A5和TPH1的mRNA和蛋白水平以及色氨酸和血清素的含量均降低,而KLF7过表达后则增强。增加血清素含量可恢复体外肿瘤细胞的恶性程度和体内肿瘤生长。相反,降低血清素含量可抑制肝癌细胞增殖。KLF7的结合活性位于SLC1A5的启动子上,KLF7正向调节SLC1A5的表达。KLF7通过上调SLC1A5促进肝癌细胞的增殖和迁移。总体而言,KLF7通过调节色氨酸代谢促进肝癌进展。肝癌中新发现的KLF7/SLC1A5轴可能代表肝癌治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/9788c708a4a8/JCMM-28-e70245-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/05240e461930/JCMM-28-e70245-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/22c803d2d376/JCMM-28-e70245-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/a5fdb60c74e8/JCMM-28-e70245-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/563ac4a6655e/JCMM-28-e70245-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/e6c060efa176/JCMM-28-e70245-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/92c22338602a/JCMM-28-e70245-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/9788c708a4a8/JCMM-28-e70245-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/05240e461930/JCMM-28-e70245-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/22c803d2d376/JCMM-28-e70245-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/a5fdb60c74e8/JCMM-28-e70245-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/563ac4a6655e/JCMM-28-e70245-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/e6c060efa176/JCMM-28-e70245-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/92c22338602a/JCMM-28-e70245-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12f1/11625504/9788c708a4a8/JCMM-28-e70245-g005.jpg

相似文献

1
KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5-Mediated Tryptophan Metabolism.KLF7通过调控SLC1A5介导的色氨酸代谢促进肝细胞癌进展。
J Cell Mol Med. 2024 Dec;28(23):e70245. doi: 10.1111/jcmm.70245.
2
LncRNA Axis Contributes to Malignant Progression of Hepatocellular Carcinoma.长链非编码 RNA 轴促进肝细胞癌的恶性进展。
Discov Med. 2023 Dec;35(179):995-1014. doi: 10.24976/Discov.Med.202335179.96.
3
[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages].[SLC1A5过表达通过促进巨噬细胞的M2极化加速肝细胞癌进展]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Feb 20;45(2):269-284. doi: 10.12122/j.issn.1673-4254.2025.02.08.
4
Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.SLC1A5 水平升高与肝细胞癌经动脉化疗栓塞治疗预后不良和耐药相关。
J Transl Med. 2024 Jun 6;22(1):543. doi: 10.1186/s12967-024-05298-1.
5
LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.长链非编码RNA NUTM2A-AS1通过激活miR-186-5p/KLF7介导的Wnt/β-连环蛋白信号通路促进肝细胞癌进展。
Hum Cell. 2023 Jan;36(1):312-328. doi: 10.1007/s13577-022-00802-5. Epub 2022 Oct 15.
6
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.Discoidin domain receptor 1 通过调节 SLC1A5 和 mTORC1 信号通路促进肝细胞癌进展。
Cell Oncol (Dordr). 2022 Feb;45(1):163-178. doi: 10.1007/s13402-022-00659-8. Epub 2022 Jan 28.
7
Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma.谷氨酰胺氨基酸转运蛋白表达重编程与肝细胞癌的预后意义。
Int J Mol Sci. 2024 Jul 10;25(14):7558. doi: 10.3390/ijms25147558.
8
The ubiquitination degradation of KLF15 mediated by WSB2 promotes lipogenesis and progression of hepatocellular carcinoma via inhibiting PDLIM2 expression.由WSB2介导的KLF15泛素化降解通过抑制PDLIM2表达促进脂肪生成和肝细胞癌进展。
J Gastroenterol Hepatol. 2025 Jan;40(1):192-207. doi: 10.1111/jgh.16812. Epub 2024 Dec 5.
9
The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine.tRNA Gm18 甲基转移酶 TARBP1 通过谷氨酰胺的代谢重编程促进肝细胞癌进展。
Cell Death Differ. 2024 Sep;31(9):1219-1234. doi: 10.1038/s41418-024-01323-4. Epub 2024 Jun 12.
10
Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.失调的 Krüppel 样因子 4 和维生素 D 受体信号通路促进肝细胞癌的进展。
Gastroenterology. 2012 Sep;143(3):799-810.e2. doi: 10.1053/j.gastro.2012.05.043. Epub 2012 Jun 4.

引用本文的文献

1
Construction of a prognostic model for hepatocellular carcinoma based on necrosis by sodium overload-related genes and identification of ANKRD13B as a new prognostic marker.基于钠超载相关基因坏死构建肝细胞癌预后模型并鉴定ANKRD13B作为新的预后标志物
Funct Integr Genomics. 2025 Sep 15;25(1):192. doi: 10.1007/s10142-025-01674-2.
2
The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy.代谢重编程对三级淋巴结构形成的影响:增强癌症免疫治疗。
BMC Med. 2025 Apr 14;23(1):217. doi: 10.1186/s12916-025-04037-7.

本文引用的文献

1
Ferroptosis-Related Gene SLC1A5 Is a Novel Prognostic Biomarker and Correlates with Immune Microenvironment in HBV-Related HCC.铁死亡相关基因SLC1A5是一种新型的预后生物标志物,与乙型肝炎病毒相关肝癌的免疫微环境相关。
J Clin Med. 2023 Feb 21;12(5):1715. doi: 10.3390/jcm12051715.
2
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2.肠道菌群失衡通过调节色氨酸代谢和上调 SREBP2 促进肝癌的发生。
Proc Natl Acad Sci U S A. 2022 Dec 27;119(52):e2203894119. doi: 10.1073/pnas.2203894119. Epub 2022 Dec 19.
3
Tryptophan metabolism and disposition in cancer biology and immunotherapy.
色氨酸代谢与分配在癌症生物学和免疫治疗中的作用。
Biosci Rep. 2022 Nov 30;42(11). doi: 10.1042/BSR20221682.
4
LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.长链非编码RNA NUTM2A-AS1通过激活miR-186-5p/KLF7介导的Wnt/β-连环蛋白信号通路促进肝细胞癌进展。
Hum Cell. 2023 Jan;36(1):312-328. doi: 10.1007/s13577-022-00802-5. Epub 2022 Oct 15.
5
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes.基于色氨酸代谢相关基因预测肝细胞癌预后及免疫治疗效果
Cancer Cell Int. 2022 Oct 10;22(1):308. doi: 10.1186/s12935-022-02730-8.
6
SP and KLF Transcription Factors in Cancer Metabolism.SP 和 KLF 转录因子在癌症代谢中的作用。
Int J Mol Sci. 2022 Sep 1;23(17):9956. doi: 10.3390/ijms23179956.
7
Hepatocellular Carcinoma.肝细胞癌。
Crit Care Nurs Clin North Am. 2022 Sep;34(3):289-301. doi: 10.1016/j.cnc.2022.04.004. Epub 2022 Jul 20.
8
Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3 E3 ligase in cancer cells.泛素化抑制通过靶向癌细胞中的 CRL3 E3 连接酶诱导谷氨酰胺摄取和代谢。
Nat Commun. 2022 May 31;13(1):3034. doi: 10.1038/s41467-022-30559-2.
9
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.Discoidin domain receptor 1 通过调节 SLC1A5 和 mTORC1 信号通路促进肝细胞癌进展。
Cell Oncol (Dordr). 2022 Feb;45(1):163-178. doi: 10.1007/s13402-022-00659-8. Epub 2022 Jan 28.
10
MiR-126-5p Promotes Tumor Cell Proliferation, Metastasis and Invasion by Targeting TDO2 in Hepatocellular Carcinoma.miR-126-5p 通过靶向 TD02 促进肝癌细胞增殖、转移和侵袭。
Molecules. 2022 Jan 10;27(2):443. doi: 10.3390/molecules27020443.